NCT03299452 Clinical Studies by Using Alphacait to Screen Drugs for Advanced Solid Tumor Status UNKNOWN Phase PHASE2
NCT03295942 A Study of OMP-336B11 in Subjects With Locally Advanced or Metastatic Tumors Status TERMINATED Phase PHASE1
NCT03277352 INCAGN01876 in Combination With Immune Therapies in Subjects With Advanced or Metastatic Malignancies Status TERMINATED Phase PHASE1/PHASE2
NCT03257007 Mindfulness to Enhance Quality of Life and Support Advance Care Planning Status COMPLETED Phase NA
NCT03249090 Electronic Patient Reporting of Symptoms During Cancer Treatment Status COMPLETED Phase NA
NCT03219775 Tailored ImmunoTherapy Approach With Nivolumab in Subjects With Metastatic or Advanced Transitional Cell Carcinoma Status UNKNOWN Phase PHASE2
NCT03176485 Evaluation of Pathway Modulation by Raf, MEK, & Kinase Inhibitors Status COMPLETED Phase NA
NCT03132038 Nivolumab in Recurrent or Metastatic Salivary Gland Carcinoma of the Head and Neck Status COMPLETED Phase PHASE2
NCT03131778 The Inflammatory Response to Stress and Angiogenesis in Liver Resection Status COMPLETED Phase NA
NCT03126110 Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of INCAGN01876 Combined With Immune Therapies in Advanced or Metastatic Malignancies Status COMPLETED Phase PHASE1/PHASE2
NCT03119428 A Study of OMP-313M32 in Subjects With Locally Advanced or Metastatic Solid Tumors Status TERMINATED Phase PHASE1
NCT03058809 Evaluation of Viatarâ„¢ Oncopheresis System in Removing CTC From Whole Blood Status UNKNOWN Phase PHASE1/PHASE2
NCT03027284 A Study of Merestinib (LY2801653) in Japanese Participants With Advanced or Metastatic Cancer Status COMPLETED Phase PHASE1
NCT03024437 Atezolizumab in Combination With Entinostat and Bevacizumab in Patients With Advanced Renal Cell Carcinoma Status TERMINATED Phase PHASE1/PHASE2
NCT03013218 A Study of Evorpacept (ALX148) in Patients With Advanced Solid Tumors and Lymphoma (ASPEN-01) Status COMPLETED Phase PHASE1
NCT03012139 Cancer-Associated Muscle Atrophy and Weakness: An Investigation of Etiology Status COMPLETED Phase N/A
NCT03009058 Study of IMM 101 in Combination With Standard of Care in Patients With Metastatic or Unresectable Cancer Status TERMINATED Phase PHASE1/PHASE2